Esta información está disponible en inglés solamente 

Geneva, Switzerland - The Global Fund to Fight AIDS, Tuberculosis and Malaria salutes Professor Awa Coll-Seck for her remarkable eight-year leadership at the Roll Back Malaria Partnership (RBM).

Professor Coll-Seck announced last week that she would not renew her term as the Executive Director of RBM. Her mandate ends on 29 February.

"Professor Coll-Seck has led RBM through a period of growth and maturation, transforming it into a partnership that has delivered truly remarkable results in the fight against malaria,” said Professor Michel Kazatchkine, Executive Director of the Global Fund. “Under her leadership, RBM has helped countries to design malaria control programs that are having such impact that we may now think and speak of ending malaria as a public health threat in many endemic countries.  I have been inspired by her dedication in the fight against malaria and I am grateful for her tireless support of the Global Fund,” he said.

Kazatchkine emphasized that Professor Coll-Seck's openness to innovation had enabled the creation of the Affordable Medicines Facility-malaria (AMFm). Hosted and managed by the Global Fund, the AMFm which is being piloted in nine countries, aims to make effective antimalarial drugs Artemisinin-combination Therapies (ACTs) accessible and affordable to patients. In Ghana for example, the AMFm drugs are sold for US$1 compared with US$8.50 for non AMFm drugs. RBM, which developed the design of the AMFm, provides support to these countries in areas such as pharmaco-vigilance, operational research, monitoring and evaluation.

The Global Fund wishes Dr. Coll-Seck all the very best in her future endeavours.

*****

The Global Fund is a unique, public-private partnership and international financing institution dedicated to attracting and disbursing additional resources to prevent and treat HIV and AIDS, TB and malaria. This partnership between governments, civil society, the private sector and affected communities represents an innovative approach to international health financing. The Global Fund’s model is based on the concepts of country ownership and performance-based funding, which means that people in countries implement their own programs based on their priorities and the Global Fund provides financing on the condition that verifiable results are achieved. 

Since its creation in 2002, the Global Fund has become the main financier of programs to fight AIDS, TB and malaria, with approved funding of US$ 22.6 billion for more than 1,000 programs in 150 countries (as of 1 December 2011). To date, programs supported by the Global Fund are providing AIDS treatment for 3.3 million people, anti-tuberculosis treatment for 8.6 million people and 230 million insecticide-treated nets for the prevention of malaria. The Global Fund works in close collaboration with other bilateral and multilateral organizations to supplement existing efforts in dealing with the three diseases. 

For more information, please contact:

ANDREW HURST
Media Relations Manager
Mobile: +41 79 561 6807
E-mail: andrew.hurst@theglobalfund.org